📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy. (2019)

First Author: Sha C

Attributed to: Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.18.01314

PubMed Identifier: 30523719

Publication URI: http://europepmc.org/abstract/MED/30523719

Type: Journal Article/Review

Volume: 37

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 3

ISSN: 0732-183X